Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.

Makers of GLP-1 drugs, including Novo Nordisk, Eli Lilly and others, are close to releasing daily pills to help shed pounds ...

The company’s experimental daily pill helped patients lose an average 16.6% of their weight, according to late-stage trial, and it could be approved in the U.S. by the end of the year.